Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that Japan’s Ministry of Health, Labour and Welfare has approved ELAPRASE, a human enzyme replacement therapy for the treatment of Hunter syndrome, for sale and marketing in Japan. Since its U.S. approval in July 2006, ELAPRASE is now approved for marketing and commercial distribution in 34 countries worldwide.
In just under a decade, hospitalizations related to all-terrain vehicles (ATVs) in Canada increased by 25%, rising from 3,296 in 1996–1997 to 4,104 in 2004–2005, according to new analysis from the Canadian Institute for Health Information (CIHI). ATVs include both snowmobiles and off-road vehicles.
The International Diabetes Federation (IDF) has published new guidelines on the contribution and impact of post-meal glucose in diabetes disease management at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) on September_19, 2007. The IDF recognises the growing evidence that post-meal glucose is a key contributor to overall glycaemic control – particularly with respect to HbA1C levels, and that reducing post-meal glucose has a significant impact on the risk of developing diabetic complications.
A post-campaign survey of AIDS Healthcare Foundation’s (AHF) innovative “Stay Negative” social marketing campaign recently revealed the initiative’s success at breaking through to its target audience and reaching its objective to create an effective health education and risk reduction campaign to raise awareness among gay males in Los Angeles County that HIV infection is still a serious threat.
New research, published today in the Journal of American Society of Nephrology by the George Institute for International Health in Sydney, has found that lowering blood pressure protects stroke victims with chronic kidney disease from further strokes or heart attacks. Given the high risk of cardiovascular complications in people with chronic kidney disease, these results have significant implications for millions of people across the world.
Paramedics with extended skills can provide a safe and effective alternative to standard ambulance transfer and hospital treatment for older people with a minor injury or illness, finds a study published online today.
An interdisciplinary team of biomedical researchers from the USC Viterbi School, the College and the Keck School of Medicine of USC has received a $6-million Bioengineering Research Partnership grant from the National Institutes of Health (NIH) to begin designing visual aids for millions of older adults who suffer from significant vision loss.
For the more than 50 million Americans who experience the phantom sounds of tinnitus — ringing in the ears that can range from annoying to debilitating — certain well-trained rats may be their best hope for finding relief.
In a significant advancement in the ongoing battle against cancer, a group of researchers from Summa Health System, IC-MedTech and other institutions have completed the first ever FDA-approved human clinical trial of Apatone®.
University of California, Irvine scientists have discovered how to reverse the learning and memory problems inherent in the most common form of mental impairment.